Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vaxcyte (PCVX) Cash from Financing Activities (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Cash from Financing Activities data on record, last reported at $601.6 million in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 79159.95% to $601.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $602.8 million, a 63.04% decrease, with the full-year FY2025 number at $2.0 million, down 99.92% from a year prior.
  • Cash from Financing Activities reached $601.6 million in Q1 2026 per PCVX's latest filing, up from $2.4 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for PCVX hit a ceiling of $1.5 billion in Q3 2024 and a floor of -$3.7 million in Q3 2025.
  • A 5-year average of $267.9 million and a median of $48.6 million in 2023 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: plummeted 100.24% in 2025, then surged 79159.95% in 2026.
  • Tracing PCVX's Cash from Financing Activities over 5 years: stood at $656.6 million in 2022, then plummeted by 99.58% to $2.7 million in 2023, then soared by 79.41% to $4.9 million in 2024, then plummeted by 50.93% to $2.4 million in 2025, then soared by 24882.68% to $601.6 million in 2026.
  • Business Quant data shows Cash from Financing Activities for PCVX at $601.6 million in Q1 2026, $2.4 million in Q4 2025, and -$3.7 million in Q3 2025.